| scholarly article | Q13442814 |
| P50 | author | Victoria Findlay | Q38523395 |
| P2093 | author name string | Xinhua Ji | |
| Gregory S Buzard | |||
| Joseph E Saavedra | |||
| Larry K Keefer | |||
| Danyelle M Townsend | |||
| Kenneth D Tew | |||
| Michael L Citro | |||
| P433 | issue | 5 | |
| P304 | page(s) | 1070-1079 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug | |
| P478 | volume | 65 |
| Q33227194 | A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins |
| Q90492246 | A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent |
| Q34544326 | A novel role for human sulfiredoxin in the reversal of glutathionylation. |
| Q37070223 | Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities |
| Q35230144 | Broad-Spectrum Anti-Cancer Activity of O-Arylated Diazeniumdiolates |
| Q34028479 | Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO |
| Q38241806 | Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death |
| Q39965769 | Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid |
| Q28476379 | Diazeniumdiolate mediated nitrosative stress alters nitric oxide homeostasis through intracellular calcium and S-glutathionylation of nitric oxide synthetase |
| Q37656625 | Gasotransmitters in cancer: from pathophysiology to experimental therapy |
| Q34024771 | Glutathione S-conjugates as prodrugs to target drug-resistant tumors |
| Q34172593 | Glutathione S-transferase P influences redox and migration pathways in bone marrow |
| Q36426775 | Glutathione S-transferase polymorphisms: cancer incidence and therapy |
| Q36363170 | Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets |
| Q37327903 | Glutathione Transferase (GST)-Activated Prodrugs. |
| Q60932204 | Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors |
| Q53787926 | Glutathione analogues as substrates or inhibitors that discriminate between allozymes of the MDR-involved human glutathione transferase P1-1. |
| Q64983490 | Glutathione and ABC transporters as determinants of sensitivity to oxidative and nitrosative stress. |
| Q48181201 | Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. |
| Q35179525 | Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas |
| Q38724701 | Human cytosolic glutathione-S-transferases: quantitative analysis of expression, comparative analysis of structures and inhibition strategies of isozymes involved in drug resistance |
| Q36095837 | NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance |
| Q35926097 | Nitric oxide release: part II. Therapeutic applications |
| Q37373297 | Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response |
| Q37029859 | Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress |
| Q40322244 | PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. |
| Q37364876 | Pleiotropic functions of glutathione S-transferase P |
| Q34318367 | Protein Disulfide Isomerase Superfamily in Disease and the Regulation of Apoptosis |
| Q24645584 | Redox-directed cancer therapeutics: molecular mechanisms and opportunities |
| Q36155865 | Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification |
| Q90669045 | Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells |
| Q35986414 | S-Glutathionylation of Protein Disulfide Isomerase Regulates Estrogen Receptor α Stability and Function |
| Q34117297 | S-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugs |
| Q37058729 | S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. |
| Q64064592 | Selective Disruption of Mitochondrial Thiol Redox State in Cells and In Vivo |
| Q55240749 | Solanine reverses multidrug resistance in human myelogenous leukemia K562/ADM cells by downregulating MRP1 expression. |
| Q33624748 | Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles |
| Q37290424 | Structure-Based Design of Anticancer Prodrug PABA/NO. |
| Q39328964 | Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents. |
| Q37074670 | Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs. |
| Q37074663 | Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound |
| Q49346285 | The dichotomous role of H2S in cancer cell biology? Déjà vu all over again. |
| Q90731554 | The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications |
| Q36754617 | Thiol Modification By Pharmacologically Active Agents of the Diazeniumdiolate Class |
Search more.